Your Story
Your Story

[Startup Bharat] Siliguri-based Desi Laundry is disrupting the laundry market with its on-demand service

[Startup Bharat] Siliguri-based Desi Laundry is disrupting the laundry market with its on-demand service
  • 589d
  • 21 shares

An increasing number of young people today find it difficult to manage everyday activities like cooking, cleaning, and laundry, due to hectic work schedule.

However, smartphone and internet penetration has made life easier for people. Startups have also come up with innovative solutions and are bringing technology to traditional industries. Dunzo, Bigbasket, Zomato, Laundry Anna, and many other startups are using technology to solve day-to-day issues. 

Nawal Bansal, Ayush Agarwal and Ashwin Agarwal, co-founders, Desi Laundry


[Startup Bharat] This Chandigarh coworking space aims to transform the startup ecosystem in Tier II and III cities


Realising the demand for such services, brothers Ayush Agarwal and Ashwin Agarwal, along with Nawal Bansal started Desi Laundry in 2019. 

The Siliguri-based startup is trying to provide solutions to the laundry segment by using technology . Desi laundry currently provides online laundry services across Siliguri.

Read more
Money Control
Money Control

Govt appoints V Anantha Nageswaran as new Chief Economic Adviser

Govt appoints V Anantha Nageswaran as new Chief Economic Adviser
  • 4hr
  • 646 shares

India's new Chief Economic Adviser V Anantha Nageswaran (Image: LikendIn)

The Government of India on January 28 appointed Dr V Anantha Nageswaran as the new Chief Economic Adviser.

Read more

J

Jagran English

DCGI permits Bharat Biotech to conduct trials for intranasal COVID-19 vaccine | All you need to know

DCGI permits Bharat Biotech to conduct trials for intranasal COVID-19 vaccine | All you need to know
  • 8hr
  • 5.6k shares

New Delhi | Jagran News Desk: Drugs Controller General of India (DCGI) permitted Hyderabad-based Bharat Biotech to conduct the Phase 3 clinical trials for its intranasal COVID-19 vaccine shot BBV154. The development comes three weeks after the Subject Expert Committee of the Central Drugs Standard Control Organisation (CDSO) approved Bharat Biotech's application to conduct the clinical trials for intranasal COVID-19 vaccine.


Read all the latest updates on COVID-19 here.

Read more

No Internet connection

Link Copied